Cargando…
Virus in the pathogenesis of inflammatory bowel disease: role of Toll-like receptor 7/8/3
The pathogenesis of inflammatory bowel disease (IBD) is influenced by immune system malfunction, particularly innate immune receptors such as toll-like receptors. Furthermore, it is critical to investigate the extremely close association between viruses and IBD incidence. Toll-like receptors (TLRs)...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514217/ https://www.ncbi.nlm.nih.gov/pubmed/34659656 |
_version_ | 1784583341323845632 |
---|---|
author | Asadzadeh Aghdaei, Hamid Jamshidi, Negar Chaleshi, Vahid Jamshidi, Nazanin Sadeghi, Amir Norouzinia, Mohsen Zali, Mohammad Reza |
author_facet | Asadzadeh Aghdaei, Hamid Jamshidi, Negar Chaleshi, Vahid Jamshidi, Nazanin Sadeghi, Amir Norouzinia, Mohsen Zali, Mohammad Reza |
author_sort | Asadzadeh Aghdaei, Hamid |
collection | PubMed |
description | The pathogenesis of inflammatory bowel disease (IBD) is influenced by immune system malfunction, particularly innate immune receptors such as toll-like receptors. Furthermore, it is critical to investigate the extremely close association between viruses and IBD incidence. Toll-like receptors (TLRs) 3, 5, and 7 are involved in antiviral immune responses. Finding a relationship between TLR-related virus and IBD is important not only for understanding the disease pathogenesis, but also for developing effective therapies. It has been shown that influenza is expressed more severely in patients with IBD who use immune system inhibitors, and the influenza vaccine is less effective in these patients. In dendritic cells, TLR7 and TLR8 regulate the production of interferons (IFNs) and inflammatory mediators. COVID-19 causes the production of IL-6, possibly due to the induction of TLR pathways. TLR activation by SARS-CoV-2 causes inflammation and IL-1 production, which induces the production of IL-6. Understanding TLR-associated viruses’ molecular mechanisms can greatly help improve the quality of life of people with IBD. Therefore, the present study reviewed the role of TLR7, 8, and 3 in inflammatory bowel disease as well as their association with viral infections and evaluated different antagonists for the treatment of IBD. |
format | Online Article Text |
id | pubmed-8514217 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Shaheed Beheshti University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-85142172021-10-15 Virus in the pathogenesis of inflammatory bowel disease: role of Toll-like receptor 7/8/3 Asadzadeh Aghdaei, Hamid Jamshidi, Negar Chaleshi, Vahid Jamshidi, Nazanin Sadeghi, Amir Norouzinia, Mohsen Zali, Mohammad Reza Gastroenterol Hepatol Bed Bench Review Article The pathogenesis of inflammatory bowel disease (IBD) is influenced by immune system malfunction, particularly innate immune receptors such as toll-like receptors. Furthermore, it is critical to investigate the extremely close association between viruses and IBD incidence. Toll-like receptors (TLRs) 3, 5, and 7 are involved in antiviral immune responses. Finding a relationship between TLR-related virus and IBD is important not only for understanding the disease pathogenesis, but also for developing effective therapies. It has been shown that influenza is expressed more severely in patients with IBD who use immune system inhibitors, and the influenza vaccine is less effective in these patients. In dendritic cells, TLR7 and TLR8 regulate the production of interferons (IFNs) and inflammatory mediators. COVID-19 causes the production of IL-6, possibly due to the induction of TLR pathways. TLR activation by SARS-CoV-2 causes inflammation and IL-1 production, which induces the production of IL-6. Understanding TLR-associated viruses’ molecular mechanisms can greatly help improve the quality of life of people with IBD. Therefore, the present study reviewed the role of TLR7, 8, and 3 in inflammatory bowel disease as well as their association with viral infections and evaluated different antagonists for the treatment of IBD. Shaheed Beheshti University of Medical Sciences 2021 /pmc/articles/PMC8514217/ /pubmed/34659656 Text en ©2021 RIGLD, Research Institute for Gastroenterology and Liver Diseases https://creativecommons.org/licenses/by/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Asadzadeh Aghdaei, Hamid Jamshidi, Negar Chaleshi, Vahid Jamshidi, Nazanin Sadeghi, Amir Norouzinia, Mohsen Zali, Mohammad Reza Virus in the pathogenesis of inflammatory bowel disease: role of Toll-like receptor 7/8/3 |
title | Virus in the pathogenesis of inflammatory bowel disease: role of Toll-like receptor 7/8/3 |
title_full | Virus in the pathogenesis of inflammatory bowel disease: role of Toll-like receptor 7/8/3 |
title_fullStr | Virus in the pathogenesis of inflammatory bowel disease: role of Toll-like receptor 7/8/3 |
title_full_unstemmed | Virus in the pathogenesis of inflammatory bowel disease: role of Toll-like receptor 7/8/3 |
title_short | Virus in the pathogenesis of inflammatory bowel disease: role of Toll-like receptor 7/8/3 |
title_sort | virus in the pathogenesis of inflammatory bowel disease: role of toll-like receptor 7/8/3 |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514217/ https://www.ncbi.nlm.nih.gov/pubmed/34659656 |
work_keys_str_mv | AT asadzadehaghdaeihamid virusinthepathogenesisofinflammatoryboweldiseaseroleoftolllikereceptor783 AT jamshidinegar virusinthepathogenesisofinflammatoryboweldiseaseroleoftolllikereceptor783 AT chaleshivahid virusinthepathogenesisofinflammatoryboweldiseaseroleoftolllikereceptor783 AT jamshidinazanin virusinthepathogenesisofinflammatoryboweldiseaseroleoftolllikereceptor783 AT sadeghiamir virusinthepathogenesisofinflammatoryboweldiseaseroleoftolllikereceptor783 AT norouziniamohsen virusinthepathogenesisofinflammatoryboweldiseaseroleoftolllikereceptor783 AT zalimohammadreza virusinthepathogenesisofinflammatoryboweldiseaseroleoftolllikereceptor783 |